Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0001699488-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | 2025-11-12 | COLL | Karnani Vikram | Pres, CEO, Dir | F - Tax | $47.35 | -8,983 | 97.0K | -8% | -$425.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | F | D | 8,983 | $47.35 | 96,989 | D | — | — | (F1) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units. |